In a retrospective cohort study, Giovanni Corrao and colleagues from the University of Milano-Bicocca, Italy, evaluated 115,709 individuals who were recently diagnosed with diabetes and treated with statins during the time period of 2003-2004 and followed prospectively until 2010.